214 related articles for article (PubMed ID: 3569310)
1. Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia.
Rizos I; Brachmann J; Lengfelder W; Schmitt C; von Olshausen K; Kübler W; Senges J
Eur Heart J; 1987 Feb; 8(2):154-63. PubMed ID: 3569310
[TBL] [Abstract][Full Text] [Related]
2. Intraindividual comparison of intravenous ajmaline and quinidine in patients with sustained ventricular tachycardia: effects on normal myocardium and on arrhythmia characteristics.
Lengfelder W; Senges J; Rizos I; Jauernig R; Brachmann J; von Ohlshausen K; Kübler W
Eur Heart J; 1985 Apr; 6(4):312-22. PubMed ID: 4029187
[TBL] [Abstract][Full Text] [Related]
3. Disopyramide: evaluation of electrophysiologic effects and clinical efficacy in patients with sustained ventricular tachycardia or ventricular fibrillation.
Lerman BB; Waxman HL; Buxton AE; Josephson ME
Am J Cardiol; 1983 Mar; 51(5):759-64. PubMed ID: 6829435
[TBL] [Abstract][Full Text] [Related]
4. Actions of disopyramide on potential reentrant pathways and ventricular tachyarrhythmias in conscious dogs during the late post-myocardial infarction phase.
Cobbe SM; Hoffmann E; Ritzenhoff A; Brachmann J; Kübler W; Senges J
Am J Cardiol; 1984 Jun; 53(11):1712-8. PubMed ID: 6731317
[TBL] [Abstract][Full Text] [Related]
5. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
Horowitz LN; Josephson ME; Farshidi A; Spielman SR; Michelson EL; Greenspan AM
Circulation; 1978 Dec; 58(6):986-97. PubMed ID: 709782
[TBL] [Abstract][Full Text] [Related]
6. Procainamide, disopyramide and quinidine: discordant antiarrhythmic effects during crossover comparison in patients with inducible ventricular tachycardia.
Wyse DG; Mitchell LB; Duff HJ
J Am Coll Cardiol; 1987 Apr; 9(4):882-9. PubMed ID: 3558987
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
Markel ML; Miles WM; Luck JC; Klein LS; Prystowsky EN
Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
[TBL] [Abstract][Full Text] [Related]
8. Availability of electrophysiological approach to the selection and assessment of antiarrhythmic drugs for recurrent ventricular tachycardia.
Kasanuki H; Ohnishi S; Hirosawa K
Jpn Circ J; 1983 Jan; 47(1):105-23. PubMed ID: 6827769
[TBL] [Abstract][Full Text] [Related]
9. Prolongation of ventricular refractoriness by class Ia antiarrhythmic drugs in the prevention of ventricular tachycardia induction.
Kus T; Costi P; Dubuc M; Shenasa M
Am Heart J; 1990 Oct; 120(4):855-63. PubMed ID: 2220538
[TBL] [Abstract][Full Text] [Related]
10. Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias.
Poole JE; Werner JA; Bardy GH; Graham EL; Pulaski WP; Fahrenbruch CE; Greene HL
Am Heart J; 1986 Aug; 112(2):322-6. PubMed ID: 3739884
[TBL] [Abstract][Full Text] [Related]
11. Atypical ventricular tachycardia as a manifestation of disopyramide toxicity.
Meltzer RS; Robert EW; McMorrow M; Martin RP
Am J Cardiol; 1978 Dec; 42(6):1049-53. PubMed ID: 727132
[TBL] [Abstract][Full Text] [Related]
12. Effect of antiarrhythmic therapy on delayed potentials detected by the signal-averaged electrocardiogram in patients with ventricular tachycardia after acute myocardial infarction.
Denniss AR; Ross DL; Richards DA; Cody DV; Russell PA; Young AA; Uther JB
Am J Cardiol; 1986 Aug; 58(3):261-5. PubMed ID: 3739914
[TBL] [Abstract][Full Text] [Related]
13. Drug conversion of nonsustained ventricular tachycardia to sustained ventricular tachycardia during serial electrophysiologic studies: identification of drugs that exacerbate tachycardia and potential mechanisms.
Rinkenberger RL; Prystowsky EN; Jackman WM; Naccarelli GV; Heger JJ; Zipes DP
Am Heart J; 1982 Feb; 103(2):177-84. PubMed ID: 6798855
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced narrowing of the width of the zone of entrainment as a predictor of the subsequent non-inducibility of reentrant ventricular tachycardia after an additional dose of an antiarrhythmic drug.
Aizawa Y; Chinushi M; Naitoh N; Shibata A
Heart; 1996 Feb; 75(2):165-70. PubMed ID: 8673755
[TBL] [Abstract][Full Text] [Related]
15. Comparison of electrophysiologic effects of quinidine and amiodarone in sustained ventricular tachyarrhythmias associated with coronary artery disease.
Pastor A; Almendral JM; Arenal A; Lorca MT; Delcán JL
Am J Cardiol; 1993 Dec; 72(18):1389-94. PubMed ID: 8256732
[TBL] [Abstract][Full Text] [Related]
16. Quinidine-Responsive Polymorphic Ventricular Tachycardia in Patients With Coronary Heart Disease.
Viskin S; Chorin E; Viskin D; Hochstadt A; Halkin A; Tovia-Brodie O; Lee JK; Asher E; Laish-Farkash A; Amit G; Havakuk O; Belhassen B; Rosso R
Circulation; 2019 May; 139(20):2304-2314. PubMed ID: 30696267
[TBL] [Abstract][Full Text] [Related]
17. Day-to-day reproducibility of antiarrhythmic drug trials using programmed extrastimulus techniques for ventricular tachyarrhythmias associated with coronary artery disease.
Kudenchuk PJ; Kron J; Walance CG; Cutler JE; Griffith KK; McAnulty JH
Am J Cardiol; 1990 Sep; 66(7):725-30. PubMed ID: 2399890
[TBL] [Abstract][Full Text] [Related]
18. [Antiarrhythmia effectiveness of oral sotalol in patients with coronary heart disease and ventricular tachycardias].
Trappe HJ; Klein H; Lichtlen PR
Z Kardiol; 1987 Oct; 76(10):630-4. PubMed ID: 3687165
[TBL] [Abstract][Full Text] [Related]
19. Verapamil in ventricular tachycardia.
Hasin Y; Kriwisky M; Gotsman MS
Cardiology; 1984; 71(4):199-206. PubMed ID: 6478466
[TBL] [Abstract][Full Text] [Related]
20. Concentration-response relationships of disopyramide in patients with ventricular tachycardia.
Duff HJ; Mitchell LB; Nath CF; Manyari DE; Baynton R; Wyse DG
Clin Pharmacol Ther; 1989 May; 45(5):542-7. PubMed ID: 2721110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
